Viewing StudyNCT00258713

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00258713
Status: COMPLETED
Last Update Posted: 2008-09-29
First Post: 2005-11-23
Brief Title: A 36-Week Extension to Protocol ISA04-03
Sponsor: Aurinia Pharmaceuticals Inc
Organization: Aurinia Pharmaceuticals Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Psoriasis
Keywords:
Name View
Double-Blind Method View
Randomized Controlled Trials View
Immunosuppression View
Adult View
Chronic Disease View
Dermatologic Agents View
Female View
Humans View
Male View
Middle Aged View
Severity of Illness Index View
Treatment Outcome View
Quality of Life View